Company / Operating Cash Flow per Share
Foghorn Therapeutics Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.81
FY2025
5-year range
-$2.79 / $4.63
FY2021-FY2025
Trend
+35.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-9.51 in FY2020 to $4.63 in FY2023.
Based on SEC 10-K filings.
-1.81 in FY2025.
Declined from $4.63 to $-1.81 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 35.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.81 | +35.3% |
| FY2024 | -$2.79 | -160.3% |
| FY2023 | $4.63 | +480.7% |
| FY2022 | -$1.22 | -43.1% |
| FY2021 | -$0.85 | +91.1% |
| FY2020 | -$9.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026